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Case report
A 24-year-old woman presented in June 1989 with a one month history of weakness, dizziness and unsteadiness. There was associated numbness in both feet, ringing in the ears, headache and a 3 week history of difficulty writing and typing. She gave a history of intermittent deafness over the preceding 5 years increasing over the last few months. One year prior to admission she had returned to live with her mother, found the diet unpalatable and ate less with consequent rapid weight loss.
Examination revealed moderately severe truncal and four limb cerebellar ataxia rendering her unable to walk, a peripheral sensory and motor neuropathy, sensory nerve deafness and fundal changes compatible with retinitis pigmentosa. She was strikingly thin with ichthyotic skin over her lower back, waist, upper arms and thighs.
A skin biopsy from the waist showed a hyperkeratotic epidermis. Many of the basal cells were finely vacuolated. Oil-red 0 stain demonstrated numerous fat globules within the basal cell layer and other keratinocytes ( Figure 1 ). Histology from uninvolved skin showed similar though less marked changes. Small lipid droplets were seen on electron microscopy within basal keratinocytes ( Figure 2 ). Her initial serum phytanic acid level was greater than 2000l'mol!l (normal 20-30l'mol!l). HPI'LC analysis was performed on her skin scale lipid extracts and showed free fatty acid 9.7% of lipid extract. Fatty acid analysis of scale lipid phospholipid and free fatty acids showed an excess of short chain and a reduction in long chain fatty acids. Plasma phospholipid and red cell membrane phospholipid had similar reduction in the longer chain fatty acids, linoleic acid and oleic acid. An aberrant serum peak of a complex fatty acid thought to be phytanic acid comprised 3% all serum fatty acids.
A low phytanic acid diet and four plasma exchanges resulted in large decrease in serum phytanic acid!". Weight gain was difficult on the diet. Nasogastric feeds and close supervision by the dietician were required before the patient put on weight. Her peripheral neuropathy and ability to walk have improved. Her ichthyosis disappeared gradually. There was modest improvement in her hearing. 
Discussion
This patient had an acute presentation of Refsum's disease (heredopathic atactica polyneuritiformis, HAP). The primary biochemical defect is an inability to convert dietary phytanic acid (a C20 fatty acid with methyl side groups) to alpha. hydroxyphytanic acid. This leads to an accumulation of phytanic acid most of which is deposited in adipose tissue. The rapid development of widespread neuropathy and rash which precipitated referral was preceded by a period of low calorie intake and was due to mobilization of phytanic acid from adipose tissue'. Phytanic acid can be excreted through the skin and this route must be inundated with very high serum concentrations of phytanic acid. The mechanism of the ichthyosis in HAP is unknown but there is a high epidermal labelling index", The accumulation of phytanic acid in the epidermis appears to cause an imbalance in long and short chain fatty acids and this may in turn affect corneocyte adhesiveness" This patient's excellent response to therapy underscores the importance of careful dietetic and plasma exchange intervention. The anticardiolipin or antiphospholipid (APL) syndrome was first reported in 1985 to describe the association of venous and/or arterial thromboses with antiphospholipid antibody'. The syndrome is mostly encountered in patients with systemic lupus erythematosus but has also been documented as a 'primary' disorder", Affected patients frequently have a past history of recurrent deep venous thrombosis'':". Recent reports suggest that adrenal impairment may be a manifestation of this syndrome":". We describe a patient with the 'primary' APL syndrome who developed acute adrenal insufficiency in association with his first episode of venous thrombosis.
Case report
A previously fit 33-year-old man presented with fever, productive cough, pleuritic pain, vomiting and diarrhoea. He had no past history of venous thrombosis or tuberculosis and had never received corticosteroid therapy. His chest X-ray showed a small left pleural effusion and shadowing at the right lung base. He was treated with erythromycin for presumed pneumonia.
Two days later he developed an extensive deep venous thrombosis, confirmed on venography, followed by breathlessness and haemoptysis suggesting pulmonary embolism. Treatment with heparin was started. His haemoglobin and platelet count was normal at 14.9 g.dl and 292 x 10 9/l respectively.
His serum sodium concentration subsequently fell from 128 mmol/l to 118 mmol/l and hyperkalaemia developed (potassium 6.5 mmol/l). A short synacthen test confirmed adrenocortical insufficiency (baseline plasma cortisol 30 nmol/l, 45 min after tetracosactrin 32 nrnol/l). Clotting studies prior to starting heparin showed a prolonged PIT at 68 sand PT at 22 s consistent with the presence of anti phospholipid antibody. The ELISA anticardiolipin IgG antibody test was strongly positive. His anti-adrenal antibody test was negative. ANF titre was 1/40 but ds DNA antibody test was negative.
He was treated with intravenous hydrocortisone and has since remained well on warfarin and replacement therapy with hydrocortisone 20 mg in the morning and 10 mg at night.
Discussion
Our patient developed acute adrenal insufficiency at the time of his first deep venous thrombosis. Antiphospholipid antibody was detected in the absence of antibody against ds DNA confirming the diagnosis of the 'primary' APL syndrome.
It has been suggested that the adrenal failure in such patients may be caused by adrenal haemorrhage and/or infarction secondary to vascular occlusion of adrenal vessels (arterial or venous) or perhaps to anticoagulant therapy", However, anticoagulant control has been reported as generally satisfactory, without evidence of bleeding elsewhere, in patients developing acute adrenal haemorrhage while taking anticoagulants". Nevertheless recent or previous adrenal haemorrhage of whatever cause has been reported in instances where computerized tomography has been performed in patients with the 'primary' APL syndromes". In one patient bilateral haemorrhagic adrenal infarction was found in association with thrombosis of the adrenal capsular veins". The latter has been postulated as a cause of adrenal haemorrhage/infarction and for anatomical reasons the adrenal veins would appear to be susceptible to thrombosis". Anti-adrenal antibody assays when performed have proved negative, as in our patient 4 • 6 • 11 , which has been taken as evidence against an autoimmune cause for the adrenal impairment", Our experience suggests that adrenal insufficiency should be considered in all patients with thromboembolic disease, whether or not there is a past history of recurrent venous thrombosis, particularly if tests for APL antibody are positive. Such tests should always be included in the assessment of patients with adrenal insufficiency of unknown cause". The association of adrenal impairment with the APL syndrome may be commoner than hitherto appreciated and deserves recognition in standard textbooks of medicine and endocrinology.
